Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: I See Poetry in the Scientific Process ContraFect Granted Up to $6.94M to Develop Novel Therapy Against ESKAPE Pathogens Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicist I See Poetry in the Scientific Process Mar 11, 2019 09:00 am | Tré LaRosa I walk two paths: One is that of logic in my career as a scientist. In this field, it’s critical to remove emotion from the picture as much as possible. I work as a cystic fibrosis (CF) scientist so that isn’t always easy, but it is important. The other path is as a writer. My […] The post I See Poetry in the Scientific Process appeared first on Cystic Fibrosis News Today. Read More ContraFect Granted Up to $6.94M to Develop Novel Therapy Against ESKAPE Pathogens Mar 11, 2019 07:30 am | Vijaya Iyer ContraFect will receive up to $6.94 million in funding from CARB-X to support the development of their proprietary therapeutic peptides — amurins — against antibiotic-resistant bacterial infections caused by gram-negative ESKAPE pathogens. The company intends to develop these compounds as potential therapies for pulmonary exacerbations of cystic fibrosis and hospital-acquired bacterial pneumonia. CARB-X (standing for Combating Antibiotic Resistant Bacteria […] The post ContraFect Granted Up to $6.94M to Develop Novel Therapy Against ESKAPE Pathogens appeared first on Cystic Fibrosis News Today. Read More Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicist Mar 11, 2019 07:00 am | Larry Luxner With each new advance in medicine comes ethical dilemmas, from fertility treatments and newborn screening, to vaccinations, gene therapies and euthanasia. But rare diseases and the expensive therapies needed to treat them — particularly in an age of scarce economic resources — almost always entail “tragic choices,” warned Avraham Steinberg, MD, an Israeli pediatric neurologist […] The post Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicistappeared first on Cystic Fibrosis News Today. Read More   Recent News Positive Data from VX-445 Triple Combo Regimen Prompt Vertex to Seek Regulatory Approval Window for More Effective Treatment of CF Lung Infections is 2 to 3 Years, Study Suggests How Does Cystic Fibrosis Affect Our Fear of Failure? NIH Rare Disease Day Highlights Joint Networks Advancing Array of Research Translate Bio Advancing MRT5005 Through Ongoing Phase 1/2 Trial in CF Patients